Rosacea: The cytokine and chemokine network

Journal of Investigative Dermatology Symposium Proceedings

Volumn 15, Issue 1, 2011, Pages 40-47

  Gerber, Peter Arne ^a   Buhren, Bettina Alexandra ^a   Steinhoff, Martin ^b   Homey, Bernhard ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTROPHIN 1; CHEMOKINE; CILIARY NEUROTROPHIC FACTOR; CYTOKINE; GLUCOCORTICOID; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HORMONE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 11; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 3; INTERLEUKIN 31; INTERLEUKIN 33; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 9; LEUKEMIA INHIBITORY FACTOR; MATRIX METALLOPROTEINASE; NEUROPEPTIDE; ONCOSTATIN M; REACTIVE OXYGEN METABOLITE; TOLL LIKE RECEPTOR; UNINDEXED DRUG;

CLINICAL FEATURE; COLD; CONFERENCE PAPER; CYTOKINE PRODUCTION; DENDRITIC CELL; HEAT; HUMAN; IMMUNITY; MACROPHAGE; MAST CELL; MICROORGANISM; MONOCYTE; NEUTROPHIL; PATHOPHYSIOLOGY; ROSACEA; SIGNAL TRANSDUCTION; SPICE; STRESS; TH1 CELL; TH17 CELL; TH2 CELL; ULTRAVIOLET RADIATION;

EID: 80955134397     PISSN: 10870024     EISSN: 15291774     Source Type: Journal    
DOI: 10.1038/jidsymp.2011.9     Document Type: Conference Paper

References (101)

1. Afonso AA, Sobrin L, Monroy DC et al. (1999) Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci 40:2506-12 (Pubitemid 29455477)
2. Akamatsu H, Oguchi M, Nishijima S et al. (1990) The inhibition of free radical generation by human neutrophils through the synergistic effects of metronidazole with palmitoleic acid: a possible mechanism of action of metronidazole in rosacea and acne. Arch Dermatol Res 282:449-54 (Pubitemid 20350067)
3. Alcorn JF, Crowe CR, Kolls JK (2010) TH17 cells in asthma and COPD. Annu Rev Physiol 72:495-516
4. Aroni K, Tsagroni E, Kavantzas N et al. (2008) A study of the pathogenesis of rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process. Arch Dermatol Res 300:125-31
5. Bagley CJ, Woodcock JM, Stomski FC et al. (1997) The structural and functional basis of cytokine receptor activation: lessons from the common beta subunit of the granulocyte-macrophage colony-stimulating factor, interleukin-3 (IL-3), and IL-5 receptors. Blood 89:1471-82 (Pubitemid 27097437)
6. Bakar O, Demircay Z, Yuksel M et al. (2007) The effect of azithromycin on reactive oxygen species in rosacea. Clin Exp Dermatol 32:197-200 (Pubitemid 46233028)
7. Baldwin HE (2007) Systemic therapy for rosacea. Skin Therapy Lett 12:1-5, 9
8. Barton K, Monroy DC, Nava A et al. (1997) Inflammatory cytokines in the tears of patients with ocular rosacea. Ophthalmology 104:1868-74 (Pubitemid 28100344)
9. Bender A, Zapolanski T, Watkins S et al. (2008) Tetracycline suppresses ATP gamma S-induced CXCL8 and CXCL1 production by the human dermal microvascular endothelial cell-1 (HMEC-1) cell line and primary human dermal microvascular endothelial cells. Exp Dermatol 17:752-60
10. Brink N, Szamel M, Young AR et al. (2000) Comparative quantification of IL-1beta, IL-10, IL-10r, TNFalpha and IL-7 mRNA levels in UV-irradiated human skin in vivo. Inflamm Res 49:290-6 (Pubitemid 30451612)
11. Buechner SA (2005) Rosacea: an update. Dermatology 210:100-8 (Pubitemid 40463198)
12. Caricchio R, McPhie L, Cohen PL (2003) Ultraviolet B radiation-induced cell death: critical role of ultraviolet dose in inflammation and lupus autoantigen redistribution. J Immunol 171:5778-86 (Pubitemid 37467193)
13. Charo IF, Ransohoff RM (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354:610-21 (Pubitemid 43209108)
14. Chen Z, O'Shea JJ (2008) Th17 cells: a new fate for differentiating helper T cells. Immunol Res 41:87-102
15. Chung DR, Lee YS, Lee SS (2008) Kinetics of inflammatory cytokines in patients with scrub typhus receiving doxycycline treatment. J Infect 56:44-50 (Pubitemid 350253649)
16. Ciardiello F, Tortora G (2008) EGFR antagonists in cancer treatment. N Engl J Med 358:1160-74
17. De Y, Chen Q, Schmidt AP et al. (2000) LL-37, the neutrophil granule-and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 192:1069-74
18. Del Rosso JQ (2007) Recently approved systemic therapies for acne vulgaris and rosacea. Cutis 80:113-20
19. Dillon SR, Sprecher C, Hammond A et al. (2004) Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 5:752-60 (Pubitemid 39023308)
20. Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519-50
21. Eklund KK, Sorsa T (1999) Tetracycline derivative CMT-3 inhibits cytokine production, degranulation, and proliferation in cultured mouse and human mast cells. Ann N Y Acad Sci 878:689-91 (Pubitemid 29353649)
22. Elewski BE, Draelos Z, Dreno B et al. (2011) Rosacea-global diversity and optimized outcome: proposed international consensus from the Rosacea International Expert Group. J Eur Acad Dermatol Venereol 25:188-200
23. Fimmel S, Abdel-Naser MB, Kutzner H et al. (2008) New aspects of the pathogenesis of rosacea. Drug Disc Today Dis Mech 5:e103-11
24. Gerber PA, Buhren BA, Cevikbas F et al. (2010a) Preliminary evidence for a role of mast cells in epidermal growth factor receptor inhibitor-induced pruritus. J Am Acad Dermatol 63:163-5
25. Gerber PA, Buhren BA, Homey B (2011a) More on aprepitant for erlotinib-induced pruritus. N Engl J Med 364:486-7
26. Gerber PA, Buhren BA, Kurle S, Homey B (2010b) [Therapy with epidermal growth factor receptor inhibitors. Clinical spectrum of cutaneous adverse effects]. Hautarzt 61:654-61
27. Gerber PA, Hippe A, Buhren BA et al. (2009) Chemokines in tumor-associated angiogenesis. Biol Chem 390:1213-23
28. Gerber PA, Kukova G, Buhren BA et al. (2011b) Density of Demodex folliculorum in patients receiving epidermal growth factor receptor inhibitors. Dermatology 222:144-7
29. Golub LM, Lee HM, Stoner JA et al. (2008) Subantimicrobial-dose doxycycline modulates gingival crevicular fluid biomarkers of period-ontitis in postmenopausal osteopenic women. J Periodontol 79:1409-18
30. Gomaa AH, Yaar M, Eyada MM et al. (2007) Lymphangiogenesis and angiogenesis in non-phymatous rosacea. J Cutan Pathol 34:748-53 (Pubitemid 47459684)
31. Guzman-Sanchez DA, Ishiuji Y, Patel T et al. (2007) Enhanced skin blood flow and sensitivity to noxious heat stimuli in papulopustular rosacea. J Am Acad Dermatol 57:800-5 (Pubitemid 47553073)
32. Haller O, Weber F (2009) The interferon response circuit in antiviral host defense. Verh K Acad Geneeskd Belg 71:73-86
33. Harrington LE, Hatton RD, Mangan PR et al. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 6:1123-32 (Pubitemid 41541790)
34. Helm KF, Menz J, Gibson LE et al. (1991) A clinical and histopathologic study of granulomatous rosacea. J Am Acad Dermatol 25:1038-43
35. Hibi M, Nakajima K, Hirano T (1996) IL-6 cytokine family and signal transduction: a model of the cytokine system. J Mol Med 74:1-12 (Pubitemid 26035753)
36. Homey B, Muller A, Zlotnik A (2002) Chemokines: agents for the immunotherapy of cancer? Nat Rev Immunol 2:175-84
37. Hsu CK, Hsu MM, Lee JY (2009) Demodicosis: a clinicopathological study. J Am Acad Dermatol 60:453-62
38. Jain A, Sangal L, Basal E et al. (2002) Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils. Dermatol Online J 8:2
39. Jones D (2004) Reactive oxygen species and rosacea. Cutis 74:17-20, 32-14 (Pubitemid 39330113)
40. Kabashima R, Sugita K, Sawada Y et al. (2011) Increased circulating Th17 frequencies and serum IL-22 levels in patients with acute generalized exanthematous pustulosis. J Eur Acad Dermatol Venereol 25:485-8
41. Kalliolias GD, Ivashkiv LB (2010) Overview of the biology of type I interferons. Arthritis Res Ther 12(Suppl 1):S1
42. Kim J (2005) Review of the innate immune response in acne vulgaris: activation of Toll-like receptor 2 in acne triggers inflammatory cytokine responses. Dermatology 211:193-8 (Pubitemid 41415858)
43. Kim JT, Lee SH, Chun YS et al. (2011) Tear cytokines and chemokines in patients with Demodex blepharitis. Cytokine 53:94-9
44. Kis K, Bodai L, Polyanka H et al. (2006) Budesonide, but not tacrolimus, affects the immune functions of normal human keratinocytes. Int Immunopharmacol 6:358-68 (Pubitemid 43120450)
45. Kocak M, Yagli S, Vahapoglu G et al. (2002) Permethrin 5% cream versus metronidazole 0.75% gel for the treatment of papulopustular rosacea. A randomized double-blind placebo-controlled study. Dermatology 205:265-70 (Pubitemid 36158538)
46. Koczulla R, von Degenfeld G, Kupatt C et al. (2003) An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 111:1665-72 (Pubitemid 38057748)
47. Korting HC, Schollmann C (2009a) Current topical and systemic approaches to treatment of rosacea. J Eur Acad Dermatol Venereol 23:876-82
48. Korting HC, Schollmann C (2009b) Tetracycline actions relevant to rosacea treatment. Skin Pharmacol Physiol 22:287-94
49. Kulka M, Sheen CH, Tancowny BP et al. (2008) Neuropeptides activate human mast cell degranulation and chemokine production. Immunology 123:398-410 (Pubitemid 351171192)
50. Lacey N, Delaney S, Kavanagh K et al. (2007) Mite-related bacterial antigens stimulate inflammatory cells in rosacea. Br J Dermatol 157:474-81 (Pubitemid 47256121)
51. Lachgar S, Charveron M, Gall Y et al. (1999) Inhibitory effects of retinoids on vascular endothelial growth factor production by cultured human skin keratinocytes. Dermatology 199(Suppl 1):25-7 (Pubitemid 29378241)
52. Lacouture ME (2006) Mechanisms of cutaneous toxicities to EGFR inhibitors. Nat Rev Cancer 6:803-12 (Pubitemid 44450468)
53. Lazaridou E, Giannopoulou C, Fotiadou C (2011) The potential role of microorganisms in the development of rosacea. J Dtsch Dermatol Ges 9:21-5
54. Lee HM, Shin DM, Kim KK et al. (2009a) Roles of reactive oxygen species in CXCL8 and CCL2 expression in response to the 30-kDa antigen of Mycobacterium tuberculosis. J Clin Immunol 29:46-56
55. Lee Y, Kim H, Kim S et al. (2009b) Myeloid differentiation factor 88 regulates basal and UV-induced expressions of IL-6 and MMP-1 in human epidermal keratinocytes. J Invest Dermatol 129:460-7
56. Margadant C, Sonnenberg A (2010) Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing. EMBO Rep 11:97-105
57. Marionnet AV, Chardonnet Y, Viac J et al. (1997) Differences in responses of interleukin-1 and tumor necrosis factor alpha production and secretion to cyclosporin-A and ultraviolet B-irradiation by normal and transformed keratinocyte cultures. Exp Dermatol 6:22-8 (Pubitemid 27132635)
58. Marzano AV, Cugno M, Trevisan V et al. (2010) Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol 162:100-7
59. Mascia F, Mariani V, Girolomoni G et al. (2003) Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation. Am J Pathol 163:303-12 (Pubitemid 36759615)
60. Matsubara M, Girard MT, Kublin CL et al. (1991a) Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodelling cornea. Dev Biol 147:425-39 (Pubitemid 121003872)
61. Matsubara M, Zieske JD, Fini ME (1991b) Mechanism of basement membrane dissolution preceding corneal ulceration. Invest Ophthalmol Vis Sci 32:3221-37
62. Meller S, Winterberg F, Gilliet M et al. (2005) Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus. Arthritis Rheum 52:1504-16 (Pubitemid 40663942)
63. Meylan E, Tschopp J (2006) Toll-like receptors and RNA helicases: two parallel ways to trigger antiviral responses. Mol Cell 22:561-9 (Pubitemid 43817607)
64. Miyachi Y, Yoshioka A, Imamura S, Niwa Y (1986) Effect of antibiotics on the generation of reactive oxygen species. J Invest Dermatol 86:449-53 (Pubitemid 16050027)
65. Muller A, Homey B, Soto H et al. (2001) Involvement of chemokine receptors in breast cancer metastasis. Nature 410:50-6 (Pubitemid 32225831)
66. Murphy G (2004) Ultraviolet light and rosacea. Cutis 74:13-6, 32-14 (Pubitemid 39330112)
67. Numasaki M, Fukushi J, Ono M et al. (2003) Interleukin-17 promotes angiogenesis and tumor growth. Blood 101:2620-7 (Pubitemid 36857622)
68. Nunzi E, Rebora A, Hamerlinck F et al. (1980) Immunopathological studies on rosacea. Br J Dermatol 103:543-51 (Pubitemid 11243277)
69. Pastore S, Mascia F, Mariotti F et al. (2005) ERK1/2 regulates epidermal chemokine expression and skin inflammation. J Immunol 174:5047-56
70. Pauloin T, Dutot M, Joly F et al. (2009) High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells. Mol Vis 15:577-83
71. Payne WG, Ko F, Anspaugh S et al. (2006) Down-regulating causes of fibrosis with tamoxifen: a possible cellular/molecular approach to treat rhinophyma. Ann Plast Surg 56:301-5
72. Payne WG, Wang X, Walusimbi M et al. (2002) Further evidence for the role of fibrosis in the pathobiology of rhinophyma. Ann Plast Surg 48:641-5 (Pubitemid 34620160)
73. Pestka S, Krause CD, Sarkar D et al. (2004) Interleukin-10 and related cytokines and receptors. Annu Rev Immunol 22:929-79 (Pubitemid 38680445)
74. Pivarcsi A, Muller A, Hippe A et al. (2007) Tumor immune escape by the loss of homeostatic chemokine expression. Proc Natl Acad Sci USA 104:19055-60
75. Powell FC (2005) Clinical practice. Rosacea. N Engl J Med 352:793-803
76. Powell FC, Corbally N, Powell D (1993) Substance P and rosacea. J Am Acad Dermatol 28:132-3
77. Pu LL, Smith PD, Payne WG et al. (2000) Overexpression of transforming growth factor beta-2 and its receptor in rhinophyma: an alternative mechanism of pathobiology. Ann Plast Surg 45:515-9
78. Rao DA, Eid RE, Qin L et al. (2008) Interleukin (IL)-1 promotes allogeneic T cell intimal infiltration and IL-17 production in a model of human artery rejection. J Exp Med 205:3145-58
79. Raz E, Mahabaleshwar H (2009) Chemokine signaling in embryonic cell migration: a fisheye view. Development 136:1223-9
80. Rebora A (1993) The red face: rosacea. Clin Dermatol 11:225-34 (Pubitemid 23191689)
81. Robinson MR, Schwartz JF, Perkins MA (2003) Application of a novel and noninvasive skin sampling technique for analyzing cytokine-mediated inflammation in rosacea. J Toxicol 22:13-22 (Pubitemid 36529887)
82. Rufli T, Buchner SA (1984) T-cell subsets in acne rosacea lesions and the possible role of Demodex folliculorum. Dermatologica 169:1-5 (Pubitemid 14083507)
83. Salamon M, Sysa-Jedrzejowska A, Lukamowicz J et al. (2008) Concentration of selected cytokines in serum of patients with acne rosacea. Przegl Lek 65:371-4
84. Sapadin AN, Fleischmajer R (2006) Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol 54:258-65 (Pubitemid 43144395)
85. Schaller M, Sander CA, Plewig G (2003) Demodex abscesses: clinical and therapeutic challenges. J Am Acad Dermatol 49:S272-4 (Pubitemid 37314859)
86. Schauber J, Dorschner RA, Coda AB et al. (2007) Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 117:803-11 (Pubitemid 46348539)
87. Shapira L, Soskolne WA, Houri Y et al. (1996) Protection against endotoxic shock and lipopolysaccharide-induced local inflammation by tetracy-cline: correlation with inhibition of cytokine secretion. Infect Immun 64:825-8 (Pubitemid 26065554)
88. Shibata M, Katsuyama M, Onodera T et al. (2009) Glucocorticoids enhance Toll-like receptor 2 expression in human keratinocytes stimulated with Propionibacterium acnes or proinflammatory cytokines. J Invest Derma-tol 129:375-82
89. Sneddon IB (1966) A clinical trial of tetracycline in rosacea. Br J Dermatol 78:649-52
90. Steinhoff M, Stander S, Seeliger S et al. (2003) Modern aspects of cutaneous neurogenic inflammation. Arch Dermatol 139:1479-88 (Pubitemid 37433137)
91. Tartour E, Pere H, Maillere B et al. (2011) Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangio-genic therapy and the development of novel therapeutic combination with immunotherapy. Cancer Metastasis Rev 30:83-95
92. Watts TH (2005) TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 23:23-68 (Pubitemid 40563164)
93. Weaver CT, Hatton RD, Mangan PR, Harrington LE (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 25:821-52 (Pubitemid 46697925)
94. Wilkin J, Dahl M, Detmar M et al. (2002) Standard classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea. J Am Acad Dermatol 46:584-7
95. Yamasaki K, Di Nardo A, Bardan A et al. (2007) Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 13:975-80 (Pubitemid 47222043)
96. Yamasaki K, Gallo RL (2009) The molecular pathology of rosacea. J Dermatol Sci 55:77-81
97. Yamasaki K, Kanada K, Macleod DT et al. (2011) TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes. J Invest Dermatol 131:688-97
98. Ye HQ, Azar DT (1998) Expression of gelatinases A and B, and TIMPs 1 and 2 during corneal wound healing. Invest Ophthalmol Vis Sci 39:913-21 (Pubitemid 28196677)
99. Zhang J, Xu X, Rao NV et al. (2011) Novel sulfated polysaccharides disrupt cathelicidins, inhibit RAGE and reduce cutaneous inflammation in a mouse model of rosacea. PLoS One 6:e16658
100. Zlotnik A, Yoshie O (2000) Chemokines: a new classification system and their role in immunity. Immunity 12:121-7 (Pubitemid 30398626)
101. Zlotnik A, Yoshie O, Nomiyama H (2006) The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol 7:243